Fundraising Fox
Amy Kruse
InvestorChief Investment Officer, Satori Neuro at Satori Capital · Venture Partner at Prime Movers Lab
Washington DC-Baltimore Area
Writes $2M – $30M checks
Find your path to Amy
Sign up to see every warm intro you have to Amy
- Paths you didn't know you had: your email and LinkedIn already hold routes to Amy. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Venture Partner who serves on several portfolio boards. She was previously Chief Scientific Officer at Optios and VP/CTO at Cubic Global Defense, and earlier a program manager at DARPA. She holds a PhD in neuroscience.
Invests in
BiotechDeep TechEnergyHardwareMobility & TransportationSpace Tech
Deals · 6
Gilgamesh PharmaBoard seat
via Prime Movers Lab · filed Mar 2026 · $15M raise
CognixionBoard seat
via Prime Movers Lab · filed Jan 2025 · $6M raise
Motif NeurotechBoard seat
via Prime Movers Lab · filed Jan 2024 · $21.6M raise
MorphoceuticalsBoard seat
via Prime Movers Lab · filed Jan 2023 · $9.8M raise
Dodo OmniDataBoard seat
via Prime Movers Lab · filed Nov 2021 · $6M raise
Gilgamesh PharmaceuticalsBoard seat
via Prime Movers Lab · filed May 2021 · $34.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Sources: SEC Form D filings · curated public sources.
Colleagues at Satori Capital
Network9
Investors connected to Amy in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Amy Kruse?
- Venture Partner who serves on several portfolio boards. She was previously Chief Scientific Officer at Optios and VP/CTO at Cubic Global Defense, and earlier a program manager at DARPA. She holds a PhD in neuroscience.
- Where does Amy Kruse work?
- Amy Kruse is Chief Investment Officer, Satori Neuro at Satori Capital and Venture Partner at Prime Movers Lab.
- What does Amy Kruse invest in?
- Amy Kruse invests in Biotech, Deep Tech, Energy, Hardware, Mobility & Transportation, Space Tech.
- What check size does Amy Kruse write?
- Amy Kruse typically writes checks of $2M – $30M.
- What boards does Amy Kruse sit on?
- Amy Kruse holds tracked board seats at Cognixion, Dodo OmniData, Gilgamesh Pharma, Gilgamesh Pharmaceuticals, Morphoceuticals, Motif Neurotech, Paradromics.
- What companies has Amy Kruse invested in?
- Investments tracked here include Beckley Psytech, Cognixion, Dimension Bio, Feel Therapeutics, Gilgamesh Pharmaceuticals, Iridia, Morphoceuticals, Motif Neurotech, NextSense, Paradromics, TARA Mind.
About this profile. Compiled from public sources — Satori Capital's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights